Two months have passed since Kobayashi Pharmaceutical recalled health products containing monascus ingredients on a large scale. It was reported on the 24th that after screening about 6800 functional foods, 21 health damage reports involving 16 products, except for the products of Kobayashi Pharmaceutical, had been submitted to the consumer department. At present, it is impossible to rule out the possibility of diseases caused by these products.
It is reported that on March 22, 2024, Kobayashi Pharmaceutical Co., Ltd. announced that some consumers had kidney disease after using the health care products containing monascus ingredients produced by the company recently. Subsequently, various food and alcohol manufacturers successively recovered products related to Xiaolin Pharmaceutical Company.
As of May 1, 2024, the number of inpatients related to the use of health care products containing red koji raw materials of Xiaolin Pharmaceutical Company has reached 270 in total.
This article is an original article. If it is reproduced, please indicate the source: Group pictures! Kobayashi Pharmaceutical of Japan contains monascus health care products or causes multiple cases of health damage https://news.zol.com.cn/874/8742238.html
https://news.zol.com.cn/874/8742238.html
news.zol.com.cn
true
Zhongguancun Online
https://news.zol.com.cn/874/8742238.html
report
four hundred and ninety-four
Two months have passed since Kobayashi Pharmaceutical recalled health products containing monascus ingredients on a large scale. It was reported on the 24th that after screening about 6800 functional foods, 21 health damage reports involving 16 products, except for the products of Kobayashi Pharmaceutical, had been submitted to the consumer department. At present, it is impossible to rule out the possibility of diseases caused by these products. It is reported that on March 22, 2024
